Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
TransUnion's (TRU) New Partnership Set to Improve Digital Leasing
by Zacks Equity Research
TransUnion's (TRU) partnership with Funnel Leasing combines its rental screening solutions likeResidentScore and ResidentID products with the Funnel platform.
Reasons to Retain Booz Allen Hamilton (BAH) in Your Portfolio
by Zacks Equity Research
Booz Allen Hamilton's (BAH) solutions business creates differentiated business models and sales channels.
TransUnion (TRU) Teams Up With UMortgage, FinLocker for USafe App
by Zacks Equity Research
The partnership enables consumers to use the USafe app powered by FinLocker to track their credit health through TransUnion (TRU).
Reasons to Hold Broadridge (BR) Stock in Your Portfolio
by Zacks Equity Research
Broadridge (BR) has a consistent track record of rewarding shareholders through dividends.
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
What's in the Cards for Accenture (ACN) in Q2 Earnings?
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings and revenues are expected to have improved year over year.
What's in the Cards for Hut 8 Mining (HUT) in Q4 Earnings?
by Zacks Equity Research
Hut 8 Mining's (HUT) fourth-quarter 2021 earnings and revenues are expected to have improved year over year.
Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $19.22 in the latest trading session, marking a +0.68% move from the prior day.
6 Reasons to Add Robert Half (RHI) Stock to Your Portfolio Now
by Zacks Equity Research
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market, and is also a solid revenue performer.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio
by Zacks Equity Research
The recent acquisition of Cobalt Software is expected to enhance FactSet's (FDS) data and workflow solutions, and expand its private markets offering.
5 Reasons to Add ABM Industries (ABM) Stock to Your Portfolio
by Zacks Equity Research
The acquisition of Able Services is expected to strengthen ABM Industries' engineering and technical services, and expand its sustainability and energy efficiency offerings.
Reasons to Hold Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) prioritizes improving its business operating system and innovation through transformation initiatives and investments.
Republic Services (RSG) Benefits From Acquisitions, Debt Ails
by Zacks Equity Research
Republic Services' (RSG) top line benefits from the favorable impact of acquisitions and internal growth.
Here's Why You Should Hold on to S&P Global (SPGI) Stock Now
by Zacks Equity Research
S&P Global's (SPGI) focus on improving foundational capabilities and core businesses with a view to enhance and differentiate customer experience.
Verisk Analytics (VRSK) Up 7.5% in a Year: What's Behind It?
by Zacks Equity Research
Consecutive better-than-expected bottom-line performance, shareholder-friendly moves and contributions from acquisitions have been benefiting Verisk's (VRSK) stock.
Rollins (ROL) Continues to Ride on Acquisitions as Debt Ails
by Zacks Equity Research
Rollins (ROL) is a consistent dividend payer with a balanced approach to organic and inorganic growth.
6 Reasons Why You Should Invest in Clean Harbors (CLH) Stock
by Zacks Equity Research
Strategic capital investments with improved business efficiency, diversified service offerings and buyouts should drive Clean Harbors' (CLH) prospects.
WEX Rides on Buyouts and Product Excellence Amid High Debt
by Zacks Equity Research
The acquisition of benefitexpress expands WEX's offerings in benefits administration by bringing in a complementary suite of solutions to its Health offerings.
5 Broker-Friendly Stocks to Buy Despite the Current Jitters
by Maharathi Basu
Broker-favorite stocks like Asbury Automotive (ABG), Cross Country Healthcare (CCRN), Arrow (ARW), Builders FirstSource (BLDR) and The Andersons (ANDE) should grace one's portfolio.
FLEETCOR (FLT) to Gain From Levarti Acquisition: Here's How
by Zacks Equity Research
The deal is expected to strengthen FLEETCOR's (FLT) airline lodging business.
Interpublic (IPG) Up on Diverse Workforce, Digital Capabilities
by Zacks Equity Research
Interpublic (IPG) continues to invest in technology and internationalize its digital specialist agencies to keep pace with the rapidly evolving media landscape.
ICF International (ICFI) Banking on Prudent Strategies, Costs Ail
by Zacks Equity Research
The recent acquisition of Creative Systems and Consulting expands ICF International's (ICF) federal IT modernization/digital transformation capabilities.
What's in the Cards for ABM Industries (ABM) in Q1 Earnings?
by Zacks Equity Research
ABM Industries' (ABM) first-quarter fiscal 2022 revenues are likely to have improved year over year while earnings have declined.
Is Cross Country (CCRN) Stock a Solid Choice Right Now?
by Zacks Equity Research
Cross Country (CCRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Verisk (VRSK) to Benefit From Opta Acquisition: Here's How
by Zacks Equity Research
The deal is expected to strengthen Verisk's (VRSK) position in the Canadian market.